Public award record

Expansion of Spleen Australia Services into Western Australia

Location
Gascoyne Goldfields/Esperance Great Southern Kimberley Mid West Peel Perth Metropolitan Pilbara South West Wheatbelt
Public buyer
Department of Health (Royal Street)
AWARD DETAILS
Buyer
Department of Health (Royal Street)
State
WA
Published
Contract start
—
Category
Immunologic prevention or control services - (100%)
Value
$220.4k
Value type
(Fixed Price)
Procurement method
Other Grant
Record updated
PUBLIC RECORD

In Western Australia (WA) there are an estimated 2,000 people with asplenia/hyposplenism (people without a spleen, or who have reduced splenic function). People with asplenia/hyposplenism have a 5% lifetime risk of severe overwhelming post splenectomy infection (OPSI). These infections have a mortality of 50-80% and survivors are often left with significant disabilities (e.g. limb amputations; neurological injury; chronic organ dysfunction). Every OPSI episode is estimated to cost between $50,000 and $280,000. The societal costs are expected to be much greater, with many of these episodes being preventable. Patients in WA with asplenia/hyposplenism currently rely on the expertise of their treating health practitioners to provide appropriate care and assistance. Many patients and clinicians in WA feel that there is a lack of resources and support in WA and accessing service that caters to patients with asplenia/hyposplenism, such as Spleen Australia, would make a significant difference to their lives. The provisions of this Grant Agreement will enable Alfred Health (Spleen Australia) to recruit a Specialist Spleen Nurse, enabling the expansion of Spleen Australia services to WA. This grant is for the provision of a Specialist Spleen Nurse to expand the services of Spleen Australia to patients in WA with asplenia/hyposplenism and their treating healthcare practitioners.